Company intelligence / Profile preview

SRW Products

Ownership: Private
Development stage: Other

Overview

SRW Laboratories commercializes premium nutraceuticals designed to support healthy aging at the cellular level. Their flagship products target hallmarks of aging using ingredients such as NMN for NAD+ replenishment and sirtuin activation. Clinical trials have supported safety and efficacy for some ingredients used in their formulations. They achieved rapid commercial success with strong sales growth in China and ongoing expansion into global markets.

Therapeutic areas: Metabolic DisordersOncologyOther
Modalities: Small molecule (e.g., NMN/nicotinamide mononucleotide, pterostilbene, astaxanthin)Nutraceuticals/Supplements
Industry: Food & Nutrition

Partnerships

Distribution partners in Chinastrategic partnerships for Amazon distribution via Noria Enterprisesadvisory board collaborations with leading scientists globally

Beyond the preview

Go deeper on SRW Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SRW Products.

Explore the full profile